These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 7140522)
21. Comparative effect of clofibrate, garlic and onion on alimentary hyperlipemia. Arora RC; Arora S Atherosclerosis; 1981 Jul; 39(4):447-52. PubMed ID: 7259824 [TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)]. Sterner W; Chibanguza G; Metz G Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056 [TBL] [Abstract][Full Text] [Related]
23. [Hypolipidemic treatment in renal insufficiency]. Synková J; Groh J; Brátová M; Zahradník J; Jánská D Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(3):385-90. PubMed ID: 6977836 [No Abstract] [Full Text] [Related]
24. [Treatment of hyperlipidemia in patients with ischemic heart disease]. Haviar V; Kusá O; Riecanský I; Luknárová O Vnitr Lek; 1972 Jun; 18(6):586-91. PubMed ID: 5044447 [No Abstract] [Full Text] [Related]
26. Is aggressive lipid lowering as effective as angioplasty in some cardiac patients? Drown DJ Prog Cardiovasc Nurs; 1999; 14(4):160-1. PubMed ID: 10689731 [No Abstract] [Full Text] [Related]
27. [The clinical and biochemical aspects of clofibrate]. Ylikahri R; Kähönen M Duodecim; 1972; 88(10):688-99. PubMed ID: 5068884 [No Abstract] [Full Text] [Related]
28. Dyslipidemia and coronary heart disease: management issues from Indian perspective. Gambhir DS; Gambhir JK; Sudha R Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772 [No Abstract] [Full Text] [Related]
29. [Prevention of coronary disease using pravastatin in men with hyperlipidemia]. Evéquoz D Praxis (Bern 1994); 1996 Aug; 85(34):989-90. PubMed ID: 8848665 [No Abstract] [Full Text] [Related]
30. Management of hyperlipidaemia: postscript. Sum CF; Tan CE; Chew LS Singapore Med J; 1995 Oct; 36(5):538. PubMed ID: 8882543 [No Abstract] [Full Text] [Related]
34. [Anti-hyperlipemic therapy in the secondary prevention of coronary heart disease. Long-term study]. Caruzzo C Boll Soc Ital Cardiol; 1974; 19(6):503-15. PubMed ID: 4282709 [No Abstract] [Full Text] [Related]
35. [Clofibrate in the primary prevention of coronary disease]. Bjerkelund C Tidsskr Nor Laegeforen; 1979 Sep; 99(25):1199-1201. PubMed ID: 505440 [No Abstract] [Full Text] [Related]
36. [Therapeutic effect of clofibrate in a patient with primary hyperlipoproteinemia type 3]. Plamieniak L Wiad Lek; 1974 May; 27(9):811-4. PubMed ID: 4849978 [No Abstract] [Full Text] [Related]
37. Untoward effects of clofibrate in hemodialyzed patients. Kijima Y; Sasaoka T; Kanayama M; Kubota S N Engl J Med; 1977 Mar; 296(9):515. PubMed ID: 834232 [No Abstract] [Full Text] [Related]
38. [Clinical experimentation with RU 19,(83 (Dabical) calcium clofibrate]. Pauchant M; Bourbillon JP Lille Med; 1976 Jan; 21(1 suppl 1):24-8. PubMed ID: 1256229 [No Abstract] [Full Text] [Related]
39. [Hypolipidemic action of simfibrate in diabetic subjects]. Gragnoli G; Tanganelli I; Signorini AM; Kristodhullu A Clin Ter; 1981 Feb; 96(4):397-408. PubMed ID: 7214862 [No Abstract] [Full Text] [Related]
40. [Effect of Clofibrate on disorders in lipid metabolism. I]. Szybiński Z; Lankosz J; Kieta-Fyda A; Bobrowski A; Biczowa N; Mareczek S Przegl Lek; 1971 Oct; 28(10):668-71. PubMed ID: 5136016 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]